Abbott absorbable stent shows good results

	Tweet

Abbott Laboratories Inc’s experimental Absorb heart stent, designed to dissolve and thereby restore the blood vessel’s natural flexibility, has proven safe and effective a year after being implanted in patients, researchers said.

The findings, which follow similarly promising 6-month and 9-month data on the plastic device, were described at the annual scientific sessions of the American College of Cardiology in New Orleans.

Abbott said 6.9 percent of patients suffered major cardiac events—including heart attacks—over a 12-month period, which the device maker described as a low rate. During the same period, no blood clots were reported among patients who were far enough along in testing to be evaluated in the 101-patient study.

Absorb, like traditional metal stents, is meant to prop open heart arteries that have been cleared of plaque. But unlike the millions of metal stents that are implanted in patients each year, it does not remain fixed in the arteries for life.

“The trial’s results would be equivalent to an excellent metallic stent - that type of performance,” said Dr. Patrick Serruys, a cardiologist from Erasmus University Hospital in Rotterdam, who led the study.

The stent was approved in Europe in January, but will not be widely available there until late next year. It was cleared by European regulators even though large so-called pivotal trials have not yet been conducted on the product.

Abbott plans to begin a 500-patient pivotal trial in Europe later this year and to conduct a 2,000-patient trial in the United States by the end of 2011. It hopes to seek U.S. approval for the product in 2015, several years before any competitor.

Serruys said current stents are essentially “cages” that hamper the flexibility of arteries and make them more prone to reclogging as they develop scar tissue and plaque builds up.

He said Absorb and stents like it will likely be the next generation of stents and ultimately improve outcomes for patients.

He said bioresorbable materials have great potential for other uses, particularly for stents to repair the pulmonary arteries and aortas of babies.

“The baby will grow and the biodegradable material will disappear,” he said. “That would be one compassionate use of it, a very serious application. Otherwise, you’d be forced to reopen the baby to remove metallic stents.”

(Reporting by Ransdell Pierson and Debra Sherman; Editing by Diane Craft)

###

By Ransdell Pierson and Debra Sherman

NEW ORLEANS

RELATED STORIES:
Scientists turn skin cells into beating heart muscle   Too many people get angioplasties, study suggests   New Blood Thinner May Lower Chances of Clots in High-Risk Heart Patients: FDA   Heart Damage After Chemo Linked to Stress in Cardiac Cells   What’s good or bad for the heart, may be the same for the brain   Warfarin in Heart Failure   Increased Sudden Cardiac Death Rate Among HIV Patients   Air pollution level changes in Beijing linked with biomarkers of cardiovascular disease   Lack of basic evidence hampering prevention of sudden heart attacks in sport   Blacks Less Likely to Get Help on Scene After Cardiac Arrest: Study   Heart attack patients taken to PCI hospitals first treated faster   Cameron Health’s under-skin ICD safe, effective

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]